Table 3 CRKP distribution and the incidence of ICU-acquired infections from different infection sites
Variable | Baseline period | Period 1 | Period 2 | Period 3 | p |
|---|---|---|---|---|---|
No. cases of total CRKP | 22 | 20 | 20 | 25 | Â |
No. cases of ICU-on-admission CRKP | 1 | 3 | 2 | 12 | Â |
No. cases of ICU-acquired CRKP | 21 | 17 | 18 | 13 | Â |
Probable source of colonization/ infection of ICU-acquired CRKP | |||||
 Bloodstream n(%) | 3/21(14.3) | 6/17(35.3) | 1/18(5.6) | 1/13(7.7) | 0.11 |
 Respiratory tract n(%) | 4/21(19) | 3/17(17.6) | 5/18(27.8) | 5/13(38.5) | 0.555 |
 Skin and soft tissue n(%) | 13/21(61.9) | 7/17(41.2) | 12/18(66.7) | 3/13(23.1) | 0.058 |
 Urine tract n(%) | 1/21(4.8) | 1/17(5.9) | 0/18(0) | 4/13(25) | 0.073 |
Incidence-ICU acquired | |||||
 Incidence of CRBSI (No. of cases per 1000 catheter days) | 2.54 | 2.44 | 0.43 | 0.41 | 0.352 |
 Incidence of VAP (No. of cases per 1000 ventilator-days) | 2.84 | 0.48 | 0.49 | 0.81 | 0.41 |
 Incidence of skin and soft tissue infections (No. of cases per 1000 ICU patient-days) | 3.40 | 0.99 | 1.46 | 0.47 | 0.531 |
 Incidence of catheter-associated urinary tract infection (No. of cases per 1000 catheter days) | 0 | 0 | 0 | 0.34 | 0.63 |